{"log_id": 5560988484296184920, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.00615, "average": 0.97723, "min": 0.4985}, "location": {"width": 833, "top": 103, "height": 66, "left": 177}, "words": "醋酸阿比特龙在体内转化成阿比特龙,阿比特龙是一种雄激素生物合成抑制剂,可抑制17"}, {"probability": {"variance": 0.004116, "average": 0.964371, "min": 0.678293}, "location": {"width": 874, "top": 153, "height": 65, "left": 140}, "words": "g-羟化酶/C17,20-裂解酶(CYP17),后者在睾丸、肾上腺和前列腺肿瘤组织中表达并且是雄激"}, {"probability": {"variance": 3.5e-05, "average": 0.994375, "min": 0.979113}, "location": {"width": 195, "top": 229, "height": 33, "left": 140}, "words": "素生物合成所必需的"}, {"probability": {"variance": 0.010826, "average": 0.952544, "min": 0.468364}, "location": {"width": 818, "top": 248, "height": 64, "left": 191}, "words": "YP17催化两个连续的反应:1)通过17a-羟化酶催化孕烯醇酮和孕酮转化成各自的17a"}, {"probability": {"variance": 0.00364, "average": 0.970848, "min": 0.760203}, "location": {"width": 877, "top": 298, "height": 60, "left": 142}, "words": "羟基衍生物;2)随后在C17、20裂解酶催化下分别形成脱氢表雄酮和雄烯二酮:脱氢表雄酮"}, {"probability": {"variance": 0.004593, "average": 0.975376, "min": 0.650363}, "location": {"width": 874, "top": 346, "height": 61, "left": 147}, "words": "和雄烯二酮均为雄激素而且是睾酮的前体。阿比特龙对CYP17的抑制作用也导致肾上腺盐皮质"}, {"probability": {"variance": 1e-06, "average": 0.998625, "min": 0.996827}, "location": {"width": 132, "top": 422, "height": 29, "left": 148}, "words": "激素生成增加"}, {"probability": {"variance": 0.006902, "average": 0.973883, "min": 0.515757}, "location": {"width": 831, "top": 440, "height": 59, "left": 193}, "words": "雄激素敏感性前列腺癌可对雄激素水平降低治疗法产生应答。雄激素阻断疗法如促性腺激"}, {"probability": {"variance": 0.013432, "average": 0.954734, "min": 0.367603}, "location": {"width": 875, "top": 486, "height": 60, "left": 150}, "words": "素释放激素(GnRH)动剂或睾丸切除术可降低睾丸中雄激素生成,但不能影响肾上或肿瘤"}, {"probability": {"variance": 3e-06, "average": 0.997612, "min": 0.99446}, "location": {"width": 133, "top": 561, "height": 27, "left": 153}, "words": "中雄激素生成"}, {"probability": {"variance": 0.000549, "average": 0.989257, "min": 0.89193}, "location": {"width": 818, "top": 579, "height": 59, "left": 197}, "words": "在安慰剂对照Ⅲ期临床试验中,醋酸阿比特龙引起患者血清睾酮及其他雄激素水平降低"}, {"probability": {"variance": 0.004584, "average": 0.974158, "min": 0.708919}, "location": {"width": 472, "top": 640, "height": 43, "left": 157}, "words": "临床使用中,无需监测本品对血清睾酮水平的影响"}, {"probability": {"variance": 0.002643, "average": 0.987092, "min": 0.664682}, "location": {"width": 834, "top": 671, "height": 60, "left": 199}, "words": "血清前列腺特异性抗原(PSA)水平可能变化,但尚未证实其与患者个体的临床获益具有相"}, {"probability": {"variance": 0, "average": 0.999646, "min": 0.999438}, "location": {"width": 44, "top": 749, "height": 26, "left": 163}, "words": "关性"}, {"probability": {"variance": 5.9e-05, "average": 0.993191, "min": 0.98004}, "location": {"width": 91, "top": 836, "height": 27, "left": 164}, "words": "毒理研究"}, {"probability": {"variance": 0.007871, "average": 0.97678, "min": 0.417167}, "location": {"width": 833, "top": 853, "height": 59, "left": 207}, "words": "重复给药毒性:在大鼠13周和26周、猴13周和39周重复给药毒性试验中,在相当于约"}, {"probability": {"variance": 0.01178, "average": 0.948732, "min": 0.555815}, "location": {"width": 876, "top": 900, "height": 59, "left": 167}, "words": "天临床泰露量(AUC)一半的情况下,醋酸阿比特龙可引起循环睾酮水平下降。因此,在雄性"}, {"probability": {"variance": 0.009459, "average": 0.954016, "min": 0.576908}, "location": {"width": 869, "top": 947, "height": 57, "left": 170}, "words": "和雌性生殖系统、肾上腺、肝脏、垂体(仅见于大鼠)和雄性乳腺中观察到器官量下降租一"}, {"probability": {"variance": 0.007634, "average": 0.966761, "min": 0.538506}, "location": {"width": 871, "top": 993, "height": 59, "left": 171}, "words": "定毒性生殖器官的变化与醋酸阿比特龙的抗雄激素药理活性一致。在≥50mg/kg天(接近于"}, {"probability": {"variance": 0.00718, "average": 0.965414, "min": 0.567237}, "location": {"width": 875, "top": 1038, "height": 59, "left": 173}, "words": "人AUC)剂量给药26周后,观察到大鼠白内障发生率呈剂量依赖性增加。猴39周试验中,在"}, {"probability": {"variance": 0.008185, "average": 0.970766, "min": 0.50695}, "location": {"width": 874, "top": 1084, "height": 59, "left": 175}, "words": "更高的剂量(高于人AUC的2倍)下未观察到白内障。在4周恢复期后由醋酸阿比特龙引起"}, {"probability": {"variance": 0.000875, "average": 0.990863, "min": 0.876762}, "location": {"width": 345, "top": 1149, "height": 38, "left": 178}, "words": "的所有其他毒性得到逆转或部分恢复"}, {"probability": {"variance": 0.004588, "average": 0.9784, "min": 0.617968}, "location": {"width": 837, "top": 1177, "height": 57, "left": 219}, "words": "遗传毒性:醋酸阿比特龙和阿比特龙Ames试验,人淋巴细胞细胞遗传学试验和大鼠微核试"}, {"probability": {"variance": 1.8e-05, "average": 0.996864, "min": 0.987367}, "location": {"width": 154, "top": 1249, "height": 29, "left": 180}, "words": "验结果均为阴性"}, {"probability": {"variance": 0.010002, "average": 0.973646, "min": 0.378135}, "location": {"width": 874, "top": 1270, "height": 57, "left": 225}, "words": "生殖毒性:根据动物试验结果,醋酸阿比特龙有损伤人类生殖功能和生育力的可能性。在"}, {"probability": {"variance": 0.01227, "average": 0.946914, "min": 0.386828}, "location": {"width": 878, "top": 1320, "height": 52, "left": 184}, "words": "雄性大鼠(13和26周)和猴(39周)重复给药毒性试验中,≥50mg/kg/天(大鼠)和≥25mg/kg"}, {"probability": {"variance": 0.009288, "average": 0.959712, "min": 0.529063}, "location": {"width": 874, "top": 1363, "height": 56, "left": 185}, "words": "天(猴〕剂量下可见生殖系统萎缩、无精/精液减少症以及增生性改变,其效应与阿比特龙的抗"}, {"probability": {"variance": 0.018626, "average": 0.949663, "min": 0.432566}, "location": {"width": 873, "top": 1410, "height": 56, "left": 189}, "words": "雄激素药理活性一致。在大和猴中观察到这些效应的AUC分别是接近和大约0.6倍于人的临"}, {"probability": {"variance": 0.004481, "average": 0.955169, "min": 0.839736}, "location": {"width": 89, "top": 1481, "height": 27, "left": 191}, "words": "床暴露量"}], "language": 3}